Search results
Learn more about the Ethicon surgical technology solutions by Ethicon. Our products are backed by years of experience and a commitment to quality.
Reimagining how we heal | For over 100 years, Ethicon has stood side by side with healthcare professionals around the world, sharing the same passion to improve and save lives.
Our Product Hub was designed to provide a comprehensive overview of the Ethicon portfolio of products and solutions. With product overviews, visual imagery, features and benefits, product spec information, and an array of support content, we are here to support you. Download Product Catalog. Purchase Products.
Visit the Ethicon Product Center (EPC) for more details on Adjunctive Hemostats products. © 2021 Ethicon US, LLC. 2021 Ethicon Product Catalog | 12 EPC Order n
Nov 15, 2023 · The acquisition of GATT and the addition of its synthetic technology complements Ethicon’s current capabilities, enabling the development of innovative solutions that address critical unmet needs, such as ETHIZIA™ Hemostatic Sealing Patch which can offer sustained hemostasis in difficult to control bleeding situations.
ETHICON Johnson & Johnson | 4,190 followers on LinkedIn. At Ethicon, we believe amazing things happen when you bring people together with a common purpose. We are committed to help advance ...
Aug 11, 2021 · Ethicon, part of Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 100 years from creating the first sutures, to revolutionizing surgery with minimally invasive procedures.
Mar 26, 2020 · You are going to another regional Ethicon website. The content and products listed may not be approved or available for use in your specific region or country.
At ETHICON™ Australia, we are shaping the future of surgery through our energy, endomedical, biosurgery & wound closure solutions. Learn more about us here.
With Auris Health’s robotic platform technology, currently used in diagnostic and therapeutic procedures in the lung, Johnson & Johnson will advance its commitment to fighting lung cancer and expand its digital surgery portfolio across multiple surgical specialties.
